Explore more publications!
Health Press Bhutan
Submit Press Release

Health Press Bhutan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Bhutan.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on August 20, 2025

Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
August 20, 2025

Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates

Indeterminate GlobeNewswire
Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot
August 20, 2025

Global Enzymes Market Set to Reach $20.4 Billion by 2029 | Asia-Pacific Emerges as a Hotspot

Indeterminate GlobeNewswire
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
August 20, 2025

Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting

Indeterminate GlobeNewswire
BioAge Labs to Present at Upcoming Investor Conferences
August 20, 2025

BioAge Labs to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire
Olema Oncology to Participate in Upcoming Investor Conferences
August 20, 2025

Olema Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
August 20, 2025

Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)

Indeterminate GlobeNewswire
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
August 20, 2025

Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference

Indeterminate GlobeNewswire
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 20, 2025

Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
August 20, 2025

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity

Indeterminate GlobeNewswire
Invivyd Announces Proposed Public Offering of Common Stock
August 20, 2025

Invivyd Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire
APIX Biosciences NV announces new advances in Honeybee Nutrition
August 20, 2025

APIX Biosciences NV announces new advances in Honeybee Nutrition

Indeterminate GlobeNewswire
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
August 20, 2025

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement

Indeterminate GlobeNewswire
Global Big Data in Healthcare Market is Predicted to Cross the USD 330 Billion Mark by 2032 | DelveInsight
August 20, 2025

Global Big Data in Healthcare Market is Predicted to Cross the USD 330 Billion Mark by 2032 | DelveInsight

Indeterminate GlobeNewswire
Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight
August 20, 2025

Merkel Cell Carcinoma Market Set for Rapid Growth in the Coming 10 Years Across the 7MM | DelveInsight

Indeterminate GlobeNewswire
King Faisal Specialist Hospital Provides Nearly 300,000 Virtual Consultations in 2024
August 20, 2025

King Faisal Specialist Hospital Provides Nearly 300,000 Virtual Consultations in 2024

Indeterminate GlobeNewswire
OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
August 20, 2025

OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer

Indeterminate GlobeNewswire
OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier
August 20, 2025

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier

Indeterminate GlobeNewswire
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
August 20, 2025

BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety

Indeterminate GlobeNewswire
BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)
August 20, 2025

BioAegis Therapeutics Awarded Second FDA Fast Track Designation for Recombinant Human Gelsolin to Treat Inflammasome-Driven Decompression Sickness (DCS)

Indeterminate GlobeNewswire
EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension
August 20, 2025

EYLEA HD® (aflibercept) Injection 8 mg Applications for Expanded U.S. Label and Prefilled Syringe Receive FDA Review Period Extension

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions